Biotech companies that will lead the next decade wont just have better science, theyll have superior operating models, writes ...

Milwaukee Area Technical College unveiled a 2,000 square foot biotech classroom and lab at its downtown campus to train ...

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...

Industry leaders came away from the J.P. Morgan Healthcare Conference feeling optimism for the industry that they say is ...

In 2023, ReNAgade Therapeutics launched with $300 million to exploit an “all in one” technology solution for RNA-based therapies. That same year, Tome Biosciences emerged from stealth with $213 ...

The second-quarter earnings season has kickstarted but only a handful of biotech companies have reported so far. The current outlook is encouraging, driven by new drug approvals and positive pipeline ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

The U.S. excels at funding discovery and celebrating breakthroughs, then neglects the hard work of manufacturing them at ...

The global biotechnology industry’s technological advancements continue to spur breakthrough products in key sectors. In the medical/healthcare arena, drugs, other therapeutics, and medical devices ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

"The conditions are perfect" for biotech's big annual party in San Francisco, an industry leader told the Business Times.

Quick Read Direxion Biotech Bull 3X (LABU) doubled over the past year by delivering three times the daily biotech index ...